577 related articles for article (PubMed ID: 35244889)
1. Cannabidiol and Other Phytocannabinoids as Cancer Therapeutics.
Nahler G
Pharmaceut Med; 2022 Apr; 36(2):99-129. PubMed ID: 35244889
[TBL] [Abstract][Full Text] [Related]
2. Opposite Roles for Cannabidiol and δ-9-Tetrahydrocannabinol in Psychotomimetic Effects of Cannabis Extracts: A Naturalistic Controlled Study.
Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
J Clin Psychopharmacol; 2021 Sep-Oct 01; 41(5):561-570. PubMed ID: 34412109
[TBL] [Abstract][Full Text] [Related]
3. Unveiling the mechanism of action behind the anti-cancer properties of cannabinoids in ER
Amaral C; Trouille FM; Almeida CF; Correia-da-Silva G; Teixeira N
J Steroid Biochem Mol Biol; 2021 Jun; 210():105876. PubMed ID: 33722705
[TBL] [Abstract][Full Text] [Related]
4. The Effects of Cannabidiol and δ-9-Tetrahydrocannabinol in Social Cognition: A Naturalistic Controlled Study.
Sainz-Cort A; Jimenez-Garrido D; Muñoz-Marron E; Viejo-Sobera R; Heeroma J; Bouso JC
Cannabis Cannabinoid Res; 2024 Feb; 9(1):230-240. PubMed ID: 35881851
[No Abstract] [Full Text] [Related]
5. Phytocannabinoid Pharmacology: Medicinal Properties of
Sampson PB
J Nat Prod; 2021 Jan; 84(1):142-160. PubMed ID: 33356248
[TBL] [Abstract][Full Text] [Related]
6. Using the BMD Approach to Derive Acceptable Daily Intakes of Cannabidiol (CBD) and Tetrahydrocannabinol (THC) Relevant to Electronic Cigarette Liquids.
Hindelang P; Scharinger A; Richling E; Walch SG; Lachenmeier DW
Front Biosci (Landmark Ed); 2022 Jul; 27(8):228. PubMed ID: 36042166
[TBL] [Abstract][Full Text] [Related]
7. Cannabis and its constituents for cancer: History, biogenesis, chemistry and pharmacological activities.
Lal S; Shekher A; Puneet ; Narula AS; Abrahamse H; Gupta SC
Pharmacol Res; 2021 Jan; 163():105302. PubMed ID: 33246167
[TBL] [Abstract][Full Text] [Related]
8. Phytocannabinoids: Exploring Pharmacological Profiles and Their Impact on Therapeutical Use.
Blebea NM; Pricopie AI; Vlad RA; Hancu G
Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673788
[TBL] [Abstract][Full Text] [Related]
9. Source of cannabinoids: what is available, what is used, and where does it come from?
Specchio N; Pietrafusa N; Cross HJ
Epileptic Disord; 2020 Jan; 22(S1):1-9. PubMed ID: 31941643
[TBL] [Abstract][Full Text] [Related]
10. Neuropharmacological Effects of the Main Phytocannabinoids: A Narrative Review.
Dos Santos RG; Hallak JEC; Crippa JAS
Adv Exp Med Biol; 2021; 1264():29-45. PubMed ID: 33332002
[TBL] [Abstract][Full Text] [Related]
11. Examining the role of cannabinoids on osteoporosis: a review.
Clouse G; Penman S; Hadjiargyrou M; Komatsu DE; Thanos PK
Arch Osteoporos; 2022 Nov; 17(1):146. PubMed ID: 36401719
[TBL] [Abstract][Full Text] [Related]
12. Acute effects of Δ
Greenwood LM; Broyd SJ; van Hell HH; Todd J; Jones A; Murray RM; Croft RJ; Michie PT; Solowij N
Psychopharmacology (Berl); 2022 May; 239(5):1409-1424. PubMed ID: 34719731
[TBL] [Abstract][Full Text] [Related]
13. A randomised controlled trial of vaporised Δ
Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R
Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105
[TBL] [Abstract][Full Text] [Related]
14. Neuroprotective Effects of Cannabidiol but Not Δ
Landucci E; Mazzantini C; Lana D; Davolio PL; Giovannini MG; Pellegrini-Giampietro DE
Int J Mol Sci; 2021 Sep; 22(18):. PubMed ID: 34575932
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Potential of Cannabis, Cannabidiol, and Cannabinoid-Based Pharmaceuticals.
Legare CA; Raup-Konsavage WM; Vrana KE
Pharmacology; 2022; 107(3-4):131-149. PubMed ID: 35093949
[TBL] [Abstract][Full Text] [Related]
16. In Vitro Evidence of Selective Pro-Apoptotic Action of the Pure Cannabidiol and Cannabidiol-Rich Extract.
Śledziński P; Nowak-Terpiłowska A; Rzymski P; Słomski R; Zeyland J
Molecules; 2023 Dec; 28(23):. PubMed ID: 38067615
[TBL] [Abstract][Full Text] [Related]
17. THC-Reduced
Bartkowiak-Wieczorek J; Mądry E; Książkiewicz M; Winkler-Galicki J; Szalata M; Szalata M; Jiménez UE; Wielgus K; Grześkowiak E; Słomski R; Bienert A
Nutrients; 2023 Jun; 15(12):. PubMed ID: 37375550
[TBL] [Abstract][Full Text] [Related]
18. Individual and combined effects of cannabidiol and Δ
Wall MB; Freeman TP; Hindocha C; Demetriou L; Ertl N; Freeman AM; Jones AP; Lawn W; Pope R; Mokrysz C; Solomons D; Statton B; Walker HR; Yamamori Y; Yang Z; Yim JL; Nutt DJ; Howes OD; Curran HV; Bloomfield MA
J Psychopharmacol; 2022 Jun; 36(6):732-744. PubMed ID: 35596578
[TBL] [Abstract][Full Text] [Related]
19. Industrial, CBD, and Wild Hemp: How Different Are Their Essential Oil Profile and Antimicrobial Activity?
Zheljazkov VD; Sikora V; Dincheva I; Kačániová M; Astatkie T; Semerdjieva IB; Latkovic D
Molecules; 2020 Oct; 25(20):. PubMed ID: 33053634
[TBL] [Abstract][Full Text] [Related]
20. Delta-9-Tetrahydrocannabinol, Cannabidiol, and Acute Psychotomimetic States: A Balancing Act of the Principal Phyto-Cannabinoids on Human Brain and Behavior.
Ganesh S; Cortes-Briones J; Schnakenberg Martin AM; Skosnik PD; D'Souza DC; Ranganathan M
Cannabis Cannabinoid Res; 2023 Oct; 8(5):846-856. PubMed ID: 35319274
[No Abstract] [Full Text] [Related]
[Next] [New Search]
